Daniel J. Mettman, MD

Article

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

Author:: Daniel J. Mettman, MD

Publish date: August 3, 2026

Mantle cell lymphoma (MCL) accounts for 2.5% to 6.0% of non-Hodgkin lymphoma cases, with about 70% of all cases affecting men.

Read More

Article

Capturing Pathology Workload Associated With Precision Oncology

Author:: Daniel J. Mettman, MD

Publish date: May 8, 2026

Precision oncology (PO) is cancer treatment individualized to the special characteristics of a patient’s tumor.

Read More

Article

Mapping Pathology Work Associated With Precision Oncology Testing

Author:: Daniel J. Mettman, MD

Publish date: May 6, 2025

Comprehensive genomic profiling (CGP) is becoming progressively common and appropriate as the array of molecular targets expands.

Read More